Ocuphire Pharma Ownership | Who Owns Ocuphire Pharma?

Ocuphire Pharma Ownership Summary

Ocuphire Pharma is owned by 10.87% institutional investors, 6.11% insiders, and 83.02% retail investors. Vanguard group is the largest institutional shareholder, holding 4.05% of OCUP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.15% of its assets in Ocuphire Pharma shares.

OCUP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ocuphire Pharma	10.87%	6.11%	83.02%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	992.20K	4.05%	$1.52M
Geode capital management	265.85K	1.08%	$406.84K
Richmond brothers	191.30K	0.78%	$292.69K
Bridgeway capital management	163.74K	0.67%	$250.52K
Blackrock	106.94K	0.44%	$163.61K
Knoll capital management	100.00K	0.41%	$153.00K
State street	70.47K	0.29%	$107.82K
Morgan stanley	56.10K	0.23%	$85.84K
Susquehanna group, llp	46.58K	0.19%	$71.26K
Kestra private wealth services	42.34K	0.17%	$64.78K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Richmond brothers	191.30K	0.58%	$292.69K
Knoll capital management	100.00K	0.10%	$153.00K
Diametric capital, lp	38.03K	0.03%	$58.19K
Bridgeway capital management	163.74K	0.01%	$250.52K
Bedel financial consulting	15.00K	0.00%	$22.95K
Stokes family office	12.12K	0.00%	$18.54K
Prelude capital management	13.85K	0.00%	$21.19K
Kestra private wealth services	42.34K	0.00%	$64.78K
Empowered funds	39.30K	0.00%	$60.14K
Carsonallaria wealth management	1.00K	0.00%	$1.53K

Top Buyers

Holder	Shares	% Assets	Change
Geode capital management	265.85K	-	31.46K
Royal bank of canada	21.95K	-	21.95K
Blackrock	106.94K	-	10.22K
National bank of canada /fi/	12.00K	-	10.00K
Advisor group	21.55K	0.00%	5.05K

Top Sellers

Holder	Shares	% Assets	Change
Mai capital management	-	-	-223.97K
Rice hall james & associates	-	-	-223.59K
Renaissance	41.70K	0.00%	-93.60K
American century companies	-	-	-65.91K
Bridgeway capital management	163.74K	0.01%	-46.20K

Sold Out

Holder	Change
Ica group wealth management	-10.00
Old point trust & financial services n a	-500.00
Nbc securities	-600.00
Concourse financial group securities	-727.00
Optimum investment advisors	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	38	-24.00%	2,665,139	-21.02%	10	4.45%	11	-47.62%	14	55.56%
Mar 31, 2024	50	-3.85%	3,374,307	-9.12%	15	5.21%	21	-12.50%	9	-
Dec 31, 2023	52	-	3,712,977	-1.47%	17	5.36%	24	4.35%	9	-30.77%
Sep 30, 2023	52	-3.70%	3,768,550	2.52%	17	5.83%	23	-34.29%	13	44.44%
Jun 30, 2023	54	28.57%	3,675,843	6.33%	17	6.44%	35	66.67%	9	28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	675.82K	2.15%	-
Vanguard Institutional Extnd Mkt Idx Tr	288.95K	1.10%	-
Fidelity Extended Market Index	146.11K	0.56%	-12.99K
Bridgeway Omni Small-Cap Value N	80.40K	0.31%	-
Bridgeway Omni Small-Cap Value	80.40K	0.26%	-
iShares Micro-Cap ETF	57.65K	0.18%	-
Bridgeway Ultra-Small Company	44.04K	0.17%	-48.90K
EA Bridgeway Omni Small-Cap Value ETF	41.78K	0.16%	-
BlackRock Extended Equity Market K	36.51K	0.14%	-16.00
Fidelity Total Market Index	35.56K	0.14%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 22, 2024	Jayagopal Ashwath	Chief Scientific & Dev. Ofc.	Buy	$6.18K
May 17, 2024	Magrath George	Chief Executive Officer	Buy	$8.77K
Mar 21, 2024	SCHACHLE JOSEPH K	Chief Operating Officer	Buy	$4.10K
Mar 21, 2024	Jhaveri Nirav S.	Chief Financial Officer	Buy	$21.00K
Mar 18, 2024	Magrath George	Chief Executive Officer	Buy	$49.05K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	2	-
2024 Q1	3	-
2023 Q4	-	-
2023 Q2	-	-
2023 Q1	-	-

OCUP Ownership FAQ

Who Owns Ocuphire Pharma?

Ocuphire Pharma shareholders are primarily institutional investors at 10.87%, followed by 6.11% insiders and 83.02% retail investors. The average institutional ownership in Ocuphire Pharma's industry, Biotech Stocks , is 44.97%, which Ocuphire Pharma falls below.

Who owns the most shares of Ocuphire Pharma?

Ocuphire Pharma’s largest shareholders are Vanguard group (992.2K shares, 4.05%), Geode capital management (265.85K shares, 1.08%), and Richmond brothers (191.3K shares, 0.78%). Together, they hold 5.91% of Ocuphire Pharma’s total shares outstanding.

Does Blackrock own Ocuphire Pharma?

Yes, BlackRock owns 0.44% of Ocuphire Pharma, totaling 106.94K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 163.61K$. In the last quarter, BlackRock increased its holdings by 10.22K shares, a 10.57% change.

Who is Ocuphire Pharma’s biggest shareholder by percentage of total assets invested?

Richmond brothers is Ocuphire Pharma’s biggest shareholder by percentage of total assets invested, with 0.58% of its assets in 191.3K Ocuphire Pharma shares, valued at 292.7K$.

Who is the top mutual fund holder of Ocuphire Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Ocuphire Pharma shares, with 2.15% of its total shares outstanding invested in 675.82K Ocuphire Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools